
Profitability, historical returns, and peer comparisons.
According to Amphastar Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 10.11%. This represents a change of 300.02% compared to the average of 2.53% of the last 4 quarters.
The mean historical ROE of Amphastar Pharmaceuticals, Inc. over the last ten years is 10.29%. The current 10.11% ROE has changed -1.78% with respect to the historical average. Over the past ten years (40 quarters), AMPH's ROE was at its highest in in the June 2019 quarter at 12.32%. The ROE was at its lowest in in the March 2018 quarter at -2.22%.
Average
10.29%
Median
12.63%
Minimum
-1.73%
Maximum
21.78%
Discovering the peaks and valleys of Amphastar Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.90%
Maximum Annual ROE = 21.78%
Minimum Annual Increase = -843.46%
Minimum Annual ROE = -1.73%
| Year | ROE | Change |
|---|---|---|
| 2025 | 12.44% | -42.91% |
| 2024 | 21.78% | 1.27% |
| 2023 | 21.51% | 24.44% |
| 2022 | 17.29% | 23.99% |
| 2021 | 13.94% | 3.90% |
| 2020 | 0.35% | -97.28% |
| 2019 | 12.83% | -843.46% |
| 2018 | -1.73% | -229.16% |
| 2017 | 1.34% | -58.22% |
| 2016 | 3.20% | -439.17% |
The current ROE of Amphastar Pharmaceuticals, Inc. (AMPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.58%
5-year avg
17.39%
10-year avg
10.29%
Amphastar Pharmaceuticals, Inc.’s ROE is less than Teva Pharmaceutical Industries Limited (6.35%), less than Amneal Pharmaceuticals, Inc. (131.71%), greater than Viatris Inc. (-2.79%), less than Dr. Reddy's Laboratories Limited (7.37%), less than Bausch Health Companies Inc. (58.90%), greater than China Pharma Holdings, Inc. (-17.14%), greater than Aytu BioPharma, Inc. (-52.89%), less than Eton Pharmaceuticals, Inc. (40.13%), less than Collegium Pharmaceutical, Inc. (15.96%),
| Company | ROE | Market cap |
|---|---|---|
| 6.35% | $48.77B | |
| 131.71% | $6.95B | |
| -2.79% | $22.08B | |
| 7.37% | $12.30B | |
| 58.90% | $3.12B | |
| -17.14% | $25.28M | |
| -52.89% | $20.86M | |
| 40.13% | $1.45B | |
| 15.96% | $770.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amphastar Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amphastar Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Amphastar Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Amphastar Pharmaceuticals, Inc. (AMPH)?
What is the highest ROE for Amphastar Pharmaceuticals, Inc. (AMPH)?
What is the 3-year average ROE for Amphastar Pharmaceuticals, Inc. (AMPH)?
What is the 5-year average ROE for Amphastar Pharmaceuticals, Inc. (AMPH)?
How does the current ROE for Amphastar Pharmaceuticals, Inc. (AMPH) compare to its historical average?